Cremophor EL-containing paclitaxel-induced anaphylaxis: a call to action-Reference-Cited by-同舟云学术

Cremophor EL-containing paclitaxel-induced anaphylaxis: a call to action

Published:2009-03 Issue:3 Volume:6 Page:132-134
ISSN:1548-5315
Container-title:Community Oncology
language:en
Short-container-title:Community Oncology

Author:

Irizarry Lauren D.,Luu Thanh Ha,McKoy June M.,Samaras Athena T.,Fisher Matthew J.,Carias Edson E.,Raisch Dennis W.,Calhoun Elizabeth A,Bennett Charles L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference11 articles.

1. Prevention and management of antineoplastic-in-duced hypersensitivity reactions;Zanotti;Drug Saf,2001

2. Taxol Science and Applications,1995

3. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation;Gelderblom;Eur J Cancer,2001

4. Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review;Volcheck;Ann Allergy Asthma Immunol,1998

5. Hypersensitivity reactions from Taxol;Weiss;J Clin Oncol,1990

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multifunctional drug delivery system based on switchable peptide-stabilized emulsions;Chem;2024-06

2. PEGylated mesoporous silica core–shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells;International Journal of Pharmaceutics;2024-04

3. A Multifunctional Drug Delivery System Based on Switchable Peptide-Stabilized Emulsions;2023-07-20

4. The Usefulness of Nanotechnology in Improving the Prognosis of Lung Cancer;Biomedicines;2023-02-24

5. Research Progress of PSOX Chemotherapy Regimen in Gastric Cancer;Advances in Clinical Medicine;2023